Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : idexx labs(idxx) -- Ignore unavailable to you. Want to Upgrade?

To: Steve LaRiviere who wrote (232)	8/13/1999 10:04:00 PM
From: Steve LaRiviere	Respond to of 233

IDEXX Announces Share Repurchase Business Wire - August 13, 1999 09:10 WESTBROOK, Maine--(BW HealthWire)--August 13, 1999--IDEXX Laboratories, Inc. NASDAQ:IDXX) announced that its Board of Directors has authorized the repurchase of up to 2,000,000 shares of the Company's common stock in the open market or in negotiated transactions. The timing and amount of any repurchases will be at the discretion of the Company's management. According to David Shaw, President and CEO, "Our decision to authorize a stock repurchase program reflects high confidence in future growth prospects for IDEXX. At the same time, we intend to maintain a strong balance sheet to support continued business development activities in diagnostics, pharmaceuticals, information technology and other areas." IDEXX Laboratories, Inc. (www.idexx.com) is a world leader in providing diagnostic, detection and information systems for veterinary, food and water testing applications. The Company's largest business is focused on animal health, combining biotechnology and information technology to create new opportunities and solutions for today's veterinary industry. Its veterinary business includes in-clinic diagnostic products, diagnostic reference laboratories and professional services, computer software and related informatics, and pharmaceuticals. Headquartered in Westbrook, Maine, IDEXX employs more than 2,000 people and offers over 350 products to customers in more than 50 countries. This press release contains forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, those that are discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 1998, and Quarterly Report on Form 10-Q for the quarter ended March 31, 1999, in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations." CONTACT: IDEXX Laboratories, Inc. Ralph K. Carlton (207) 856-8155 investorrelations@idexx.com